2011 Form 10-K Financial Statement
#000114420413016910 Filed on March 22, 2013
Income Statement
| Concept | 2011 |
|---|---|
| Revenue | $100.0K |
| YoY Change | |
| Cost Of Revenue | $60.00K |
| YoY Change | |
| Gross Profit | $40.00K |
| YoY Change | |
| Gross Profit Margin | 40.0% |
| Selling, General & Admin | $3.790M |
| YoY Change | 83.09% |
| % of Gross Profit | 9475.0% |
| Research & Development | $0.00 |
| YoY Change | |
| % of Gross Profit | 0.0% |
| Depreciation & Amortization | $0.00 |
| YoY Change | |
| % of Gross Profit | 0.0% |
| Operating Expenses | $0.00 |
| YoY Change | -100.0% |
| Operating Profit | $40.00K |
| YoY Change | -101.7% |
| Interest Expense | -$380.0K |
| YoY Change | -138.0% |
| % of Operating Profit | -950.0% |
| Other Income/Expense, Net | |
| YoY Change | |
| Pretax Income | -$4.490M |
| YoY Change | 232.59% |
| Income Tax | $0.00 |
| % Of Pretax Income | |
| Net Earnings | -$4.490M |
| YoY Change | 232.59% |
| Net Earnings / Revenue | -4490.0% |
| Basic Earnings Per Share | |
| Diluted Earnings Per Share | -$3.465B |
| COMMON SHARES | |
| Basic Shares Outstanding | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2011 |
|---|---|
| SHORT-TERM ASSETS | |
| Cash & Short-Term Investments | $120.0K |
| YoY Change | 1100.0% |
| Cash & Equivalents | |
| Short-Term Investments | |
| Other Short-Term Assets | $30.00K |
| YoY Change | 200.0% |
| Inventory | $100.0K |
| Prepaid Expenses | |
| Receivables | $50.00K |
| Other Receivables | $0.00 |
| Total Short-Term Assets | $300.0K |
| YoY Change | 1400.0% |
| LONG-TERM ASSETS | |
| Property, Plant & Equipment | $0.00 |
| YoY Change | -100.0% |
| Goodwill | |
| YoY Change | |
| Intangibles | |
| YoY Change | |
| Long-Term Investments | |
| YoY Change | |
| Other Assets | |
| YoY Change | |
| Total Long-Term Assets | $150.0K |
| YoY Change | 0.0% |
| TOTAL ASSETS | |
| Total Short-Term Assets | $300.0K |
| Total Long-Term Assets | $150.0K |
| Total Assets | $450.0K |
| YoY Change | 164.71% |
| SHORT-TERM LIABILITIES | |
| YoY Change | |
| Accounts Payable | $730.0K |
| YoY Change | -5.19% |
| Accrued Expenses | $570.0K |
| YoY Change | 14.0% |
| Deferred Revenue | |
| YoY Change | |
| Short-Term Debt | $0.00 |
| YoY Change | |
| Long-Term Debt Due | $1.060M |
| YoY Change | 1414.29% |
| Total Short-Term Liabilities | $2.350M |
| YoY Change | 76.69% |
| LONG-TERM LIABILITIES | |
| Long-Term Debt | $630.0K |
| YoY Change | -37.62% |
| Other Long-Term Liabilities | $170.0K |
| YoY Change | 1600.0% |
| Total Long-Term Liabilities | $800.0K |
| YoY Change | -21.57% |
| TOTAL LIABILITIES | |
| Total Short-Term Liabilities | $2.350M |
| Total Long-Term Liabilities | $800.0K |
| Total Liabilities | $3.150M |
| YoY Change | 33.47% |
| SHAREHOLDERS EQUITY | |
| Retained Earnings | |
| YoY Change | |
| Common Stock | |
| YoY Change | |
| Preferred Stock | |
| YoY Change | |
| Treasury Stock (at cost) | |
| YoY Change | |
| Treasury Stock Shares | |
| Shareholders Equity | -$2.700M |
| YoY Change | |
| Total Liabilities & Shareholders Equity | $450.0K |
| YoY Change | 164.71% |
Cashflow Statement
| Concept | 2011 |
|---|---|
| OPERATING ACTIVITIES | |
| Net Income | -$4.490M |
| YoY Change | 232.59% |
| Depreciation, Depletion And Amortization | $0.00 |
| YoY Change | |
| Cash From Operating Activities | -$1.780M |
| YoY Change | 117.07% |
| INVESTING ACTIVITIES | |
| Capital Expenditures | $0.00 |
| YoY Change | |
| Acquisitions | |
| YoY Change | |
| Other Investing Activities | |
| YoY Change | |
| Cash From Investing Activities | $0.00 |
| YoY Change | |
| FINANCING ACTIVITIES | |
| Cash Dividend Paid | |
| YoY Change | |
| Common Stock Issuance & Retirement, Net | |
| YoY Change | |
| Debt Paid & Issued, Net | |
| YoY Change | |
| Cash From Financing Activities | 1.900M |
| YoY Change | 134.57% |
| NET CHANGE | |
| Cash From Operating Activities | -1.780M |
| Cash From Investing Activities | 0.000 |
| Cash From Financing Activities | 1.900M |
| Net Change In Cash | 120.0K |
| YoY Change | -1300.0% |
| FREE CASH FLOW | |
| Cash From Operating Activities | -$1.780M |
| Capital Expenditures | $0.00 |
| Free Cash Flow | -$1.780M |
| YoY Change | 117.07% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2011 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
0 | shares |
| CY2012 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
0 | shares |
| CY2011 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
0 | USD |
| us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
0 | shares | |
| CY2002 | bior |
Common Stock Issued To Founders During Period Value
CommonStockIssuedToFoundersDuringPeriodValue
|
10000 | USD |
| CY2003 | bior |
Common Stock Issued During Period Value Compensation For Loan Guarantees By Management
CommonStockIssuedDuringPeriodValueCompensationForLoanGuaranteesByManagement
|
400 | USD |
| CY2005 | bior |
Common Stock Issued During Period Value Compensation For Loan Guarantees By Management
CommonStockIssuedDuringPeriodValueCompensationForLoanGuaranteesByManagement
|
250 | USD |
| CY2007 | bior |
Common Stock Issued During Period Value Compensation For Loan Guarantees By Management
CommonStockIssuedDuringPeriodValueCompensationForLoanGuaranteesByManagement
|
1000 | USD |
| CY2008 | bior |
Common Stock Issued During Period Value Compensation For Loan Guarantees By Management
CommonStockIssuedDuringPeriodValueCompensationForLoanGuaranteesByManagement
|
1593502 | USD |
| CY2003 | bior |
Common Stock Issued During Period Value Investment Including Finders Fee
CommonStockIssuedDuringPeriodValueInvestmentIncludingFindersFee
|
35000 | USD |
| CY2004 | bior |
Common Stock Issued During Period Value Payment Of Patent Legal Fees
CommonStockIssuedDuringPeriodValuePaymentOfPatentLegalFees
|
110 | USD |
| CY2006 | bior |
Common Stock Issued During Period Value Vendor Contractual Consideration
CommonStockIssuedDuringPeriodValueVendorContractualConsideration
|
1451 | USD |
| CY2006 | bior |
Common Stock Issued During Period Value Employment Agreement
CommonStockIssuedDuringPeriodValueEmploymentAgreement
|
650 | USD |
| CY2006 | bior |
Common Stock Issued During Period Value Investment
CommonStockIssuedDuringPeriodValueInvestment
|
44810 | USD |
